CNBC | Average Joe Weekly

February 10, 2022

Pfizer expects $54 billion in 2022 sales on Covid vaccine Pfizer projects it will generate record-high revenue in 2022, saying Tuesday it expects to sell $32 billion of its Covid-19 shots and $22 billion of its antiviral coronavirus treatment pill Paxlovid this year. OMG, who would have ever thought that they would turn a profit,… Continue reading Pfizer expects $54 billion in 2022 sales on Covid vaccine

Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational or personal use tips the balance in favor of fair use.

The appearance of U.S. Department of Defense (DoD) visual information does not imply or constitute DoD endorsement. Neither the United States Marine Corps nor any other component of the Department of Defense has approved, endorsed, or authorized this product (or promotion, or service, or activity) or approved, endorsed, or authorized this blog. This trainwreck is all mine.

Notice a spelling or grammar error in this article? Click or tap here to report it. Please include the article’s headline.

This blog is a personal blog written and edited by Average Joe (Pen name, my real name is hidden to help protect my privacy from nut bags). For questions about this blog, please email Joe@averagejoeweekly.com

Most of the stuff on my blog is for entertainment and educational purposes. If something offends you, I’m sorry, but pull up your big kid pants and move on.

CATEGORIES

Tag: CNBC

Pfizer expects $54 billion in 2022 sales on Covid vaccine